Treatment plan for early-stage nasal lymphoma
Treatments studied
Part of Cancer clinical trials.
This trial tests a treatment plan that uses a combination of a chemotherapy drug (pegaspargase) and radiation therapy, adjusting the treatment based on how well the cancer responds. It aims to improve outcomes for people with early-stage NK/T-cell lymphoma while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with a specific type of lymphoma called extranodal NK/T-cell lymphoma (nasal type).
- Your lymphoma is in an early stage (IE or IIE) and is located in the nose, sinuses, throat, or mouth area.
- You have not had any previous treatment for your lymphoma, such as chemotherapy, radiation, or immunotherapy.
- You are generally in good health, with adequate blood counts, liver, kidney, and heart function.
- You do not have serious infections (like HIV or active hepatitis B or C) or another active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of an immunotherapy drug (PD-1 antibody, which helps your immune system fight cancer) and radiation therapy for people with early-stage nasal-type NK/T-cell lymphoma. It aims to see if this approach is safe and effective as a first treatment.
This trial uses PET scans and EBV DNA levels to personalize treatment for patients with early-stage nasal NK/T cell lymphoma. It aims to reduce side effects by adjusting therapy based on how well the cancer responds.
This study tests whether patients with a specific type of blood cancer (NK/T-cell lymphoma) in the nose or sinuses who have responded well to chemotherapy can be safely treated with reduced radiation doses instead of standard high-dose radiation. The goal is to reduce side effects while maintaining effective treatment.
This trial compares an immunotherapy approach to standard chemotherapy as a first step before stem cell transplant for patients with advanced NK/T-cell lymphoma. It aims to see which treatment helps patients better before their own stem cells are transplanted.
This trial tests whether combining chemotherapy with radiation therapy can work well for people with early-stage NK/T-cell lymphoma that started in the nose or throat. It aims to find a more effective treatment approach with fewer side effects.
This study tests a new combination of medications for people with early-stage nasal natural killer/T-cell lymphoma. The goal is to see if adding a targeted therapy to standard treatment helps control the disease with manageable side effects.
Hear when a new Natural Killer/T-cell Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.